1.Focal Fat Sparing Area of the Liver by Aberrant Left Gastric Vein in a Background of Fatty Liver: A Report of 2 Cases
Hiroaki SHIBAHARA ; Kiyoshi MORITA ; Yuya ITO ; Katsushi OKAMOTO
Journal of the Japanese Association of Rural Medicine 2017;66(1):55-60
		                        		
		                        			
		                        			  The first patient was a 33-year-old man with a history of fatty liver disease. Dynamic computerized tomography of a lesion in liver segment IV showed faint staining in the arterial phase and high signal intensity in the portal venous and equilibrium phases. The second patient was a 57-year-old woman also with a history of fatty liver disease. Magnetic resonance imaging (MRI) of a lesion in segment II in T1 out of phase revealed geographic morphology and high signal intensity. Furthermore, Gd-EOB-DTPA-enhanced MRI showed accumulation in the lesion in the hepatobiliary phase. In both cases, an aberrant left gastric vein and focal fat sparing area was diagnosed. Venous inflow to the liver other than via the portal vein may cause fatty degeneration of liver parenchymal cells or focal fat sparing due to imbalanced intrahepatic blood flow. In the present cases, imaging revealed a focal fat sparing area with an aberrant left gastric vein. Focal fat sparing area with aberrant inflow vessel identified in the background of fatty liver does not require biopsy or surgery. Therefore, further detailed evaluation of such images is warranted.
		                        		
		                        		
		                        		
		                        	
2.Appearance of Skin Moisturization in the Final Stage of life - A Prospective Observational Study with Clinical Pathway for End-of-Life Care (Liverpool Care Pathway Japanese Version) in Palliative Care Unit
Hiroaki SHIBAHARA ; Masahito MURAMATSU ; Takahisa NIWA ; Daisaku NISHIMURA
Journal of the Japanese Association of Rural Medicine 2015;64(2):131-139
		                        		
		                        			
		                        			  Objective: To elucidate the appearance of skin moisturization (cold and clammy skin) indying period and related factors. Methods: Patients were observed prospectively with skin moisturization using the clinical pathway for end-of-life care (Liverpool Care Pathway Japanese version [LCP]) by nurses in the palliative care unit. Results: Of 213 patients placed on LCP, 48 (22.5%) indicated skin moisturization, which was observed mostly in summer and in the morning. It appeared 45.8 hours before death on the average. By multivariate analysis, the administration of non-steroidal anti-inflammatory drugs (NSAIDs) was an independent related factor. Conclusions: Compared to our previous retrospective study, the appearance of skin moisturization was higher in frequency and earlier in the dying period, and the administration of NSAIDs was an independent related factor.
		                        		
		                        		
		                        		
		                        	
3.The Relation between Self-Contribution Degree of Members of Palliative Care Team and Improvement in the Symptom Items Listed in STAS-J
Hiroaki SHIBAHARA ; Masahito MURAMATSU ; Daisaku NISHIMURA
Journal of the Japanese Association of Rural Medicine 2014;63(2):114-120
		                        		
		                        			
		                        			  Purpose: To elucidate the degree of self-conctribution of each member of a palliative care team and the palliative effect patients. Patients and Methods:The degree of self-contribution to intervened patients and the degree of improvements in the symptoms items listed in a Japanese version of the Support Team Assessment Schedule (STAS-J) were examined prospectively. Results: The degree of self-contribution was often higher in doctors, nurses, clinical psychotherapists and pharmacists, and lower in nutritionists. It was related to age, gender, site of primary disease and the duration of intervention. The symptom items which showed improvement were such items as pain, nausea, vomiting, appetite loss and insomnia, but delirium and depression worsened. The degree of self-contribution and the degree of improvement in symptom were correlated in seven items in the case of pharmacists but only in one in the case of other professionals. Discussion: The degree of self-conribution varied and was not always high even after the intervention of the care team. It was considered that the fact that the number of related items was larger in pharmacists than in any other professionals was probably because the pharmacists could assess the symptoms and propose drugs from an objective point of view, although character might be mostly involved. Conslusion: It is to be hoped that every one engaged in palliative care will do what is one’s forte and apply each one’s individuality properly in the future.
		                        		
		                        		
		                        		
		                        	
4.Kampo Treatment Experience in a Case of Suspected MRSA Infection Related Enteritis Complicated by ARDS and Shock
Tatsuya NOGAMI ; Naotoshi SHIBAHARA ; Makoto FUJIMOTO ; Hidetoshi WATARI ; Shigeru EBISAWA ; Hiroki MISAWA ; Hideyuki KITAHARA ; Sayuri ARAI ; Hiroaki HIKIAMI ; Yutaka SHIMADA
Kampo Medicine 2014;65(2):94-99
		                        		
		                        			
		                        			The patient was a 49-year-old woman. She developed retroperitonitis and retroperitoneal emphysema due to iatrogenic duodenal perforation. We inserted a nasogastric tube into her stomach in order to decompress the gastrointestinal tract, and cefoperazone and proton pump inhibitors were administered intravenously. Her symptoms of retroperitonitis were then reduced. However, she developed enteritis suspected due to MRSA infection complicated by acute respiratory distress syndrome, acute renal failure and shock. We administered vancomycin via nasogastric tube, but her symptoms did not improve, so we added shojokito. She relieved her bowels after the administration of shojokito, and an antipyretic tendency was observed. Her breathing status recovered to normal, her blood pressure was stable, and her general condition gradually improved.
In recent years, we have not had many opportunities to perform Kampo treatment for severe infection cases needing hospitalization, but Kampo application has the potential to enhance the efficacy of infection treatments. Thus we advocate the active carrying out of Kampo treatment for patients with intestinal infection.
		                        		
		                        		
		                        		
		                        	
5.Two Cases of Autoimmune Pancreatitis-Induced Obstructive Jaundice Treated with Inchinkoto
Hideyuki KITAHARA ; Tatsuya NOGAMI ; Hiroki MISAWA ; Sayuri ARAI ; Shigeru EBISAWA ; Hidetoshi WATARI ; Makoto FUJIMOTO ; Hiroshi FUJINAGA ; Hiroaki HIKIAMI ; Kozo TAKAHASHI ; Naotoshi SHIBAHARA ; Yutaka SHIMADA
Kampo Medicine 2014;65(3):202-209
		                        		
		                        			
		                        			We report two cases of inchinkoto treatment for obstructive jaundice via autoimmune pancreatitis (AIP). Case 1 : A 38-year-old male. After completion of treatment for Mikulicz disease, obstructive jaundice developed. A diagnosis of AIP was based on a high IgG 4 blood level and image views. T-Bil stayed above 20 mg/dl and there was no improvement by oral administration of prednisolone (PSL), ursodeoxycholic acid, or bilirubin adsorption therapy. Upon inchinkoto administration, T-Bil promptly fell to 3 mg/dL. Case 2 : A 77-year-old male. He suffered from itching and constipation, and blood data showed a pattern of obstructive jaundice. Image views suggested AIP, but a duodenal papillary biopsy could not provide a definitive diagnosis. Inchinkoto was administered, and the itching and constipation had mostly disappeared within 1 week. However, these symptoms recurred after one month. A definitive diagnosis of AIP was then reached based on a pancreas biopsy, and a PSL regimen was initiated. From these two cases, we consider that inchinkoto is useful for improving the symptoms of obstructive jaundice induced by AIP.
		                        		
		                        		
		                        		
		                        	
6.A Study of Indications for the Application of Kyokatsushoshitsuto
Hiroki MISAWA ; Tatsuya NOGAMI ; Hiroaki HIKIAMI ; Sayuri ARAI ; Hideyuki KITAHARA ; Shigeru EBISAWA ; Hidetoshi WATARI ; Makoto FUJIMOTO ; Naotoshi SHIBAHARA ; Yutaka SHIMADA
Kampo Medicine 2014;65(4):293-297
		                        		
		                        			
		                        			Kyokatsushoshitsuto is a Kampo formulation used against cervix pain so severe that the neck cannot be turned. Of six patients we treated with this formula, it was effective in three cases but ineffective in the remaining three. From the viewpoint of traditional Chinese medicine (Kampo) regarding the in/effectiveness of this formula : in effective cases, palpitations in the area of the navel and tooth marks on the tongue are seen in patients in a weak state. As for subjective symptoms : in effective cases, “the waist area around the body sometimes feels cold”, “air conditioning is disliked”, and “an electric blanket etc. is needed in winter” were also indicative signs. On the other hand, symptoms such as “the skin becomes dry”, “water may accumulate in a joint”, and “symptoms of clicking/pain in the knee and having difficulty sitting straight” were not seen. In total, these may serve as useful indications for the application of kyokatsushoshitsuto, especially when palpitations in the navel area are considered a helpful new Kampo finding.
		                        		
		                        		
		                        		
		                        	
7.Malignant Fibrous Histiocytoma Patient Who Survived for Over Five Months in Only Palliative Care Despite Marked Thrombocytopenia and Jaundice After Transferal to Our Hospital
Hiroaki SHIBAHARA ; Hironobu INAGAKI ; Daisaku NISHIMURA
Journal of the Japanese Association of Rural Medicine 2013;61(4):649-656
		                        		
		                        			
		                        			  The patient was a woman in her 70s, who had been diagnosed as having a malignant fibrous histiocytoma in the right axilla with invasion to the intrathoracic space at a local hospital. The growth of cytokine-producing tumor was suspected, and thrombocytopenia caused by bleeding and jaundice by blood transfusion were disclosed. When she was admitted to our palliative care unit, the platelet count was 19,000/μl and total bilirubin was 6.4mg/dl. Furthermore, several predictive fools showed the prognosis for survival was poor. After transferal to our hospital, the patient was treated mainly with medication. No blood transfusion was given. In the clinical course, the platelet count and total bilirubin level were restored to normalcy. The patient lived on for another five months or over. The contributing factors, in prolonging her life longer than predicted were probably as follows; (1) spontaneous recovery of thrombocytopenia without bleeding, (2) improvement of jaundice caused by the blood transfusion, and (3) foods taken orally even in small amounts. There are patients whose prognosis varies substantially in the fields of the palliative care. It is important to work out proper medical treatment and care plans according to symptoms and the status of patients.
		                        		
		                        		
		                        		
		                        	
8.An Experience in Administration of EPA-Enriched Nutritional Supplementation (ProSurer®) for Lung Cancer Patients with Chemotherapy
Ayako YAMAMOTO ; Hiroaki SHIBAHARA ; Masahiro AOYAMA ; Kenichi NAKAHIRA ; Atsumi HAYASHI ; Daisaku NISHIMURA
Journal of the Japanese Association of Rural Medicine 2013;62(1):21-25
		                        		
		                        			
		                        			The initial case was a man in his 50s. He received 2 cans a day of ProSure®, while undergoing radiation and chemotherapy with carboplatin and docetaxel for adenocarcinoma in the lung. His body weight rose from 62.4 kg on admission to 63.7 kg before discharge, CRP decreased from 3.08 mg/dl to 0.48 mg/dl, and albumin fell from 3.6 g/dl to 3.5 g/dl. The second case was a man in his 60s. He was diagnosed as having squamous cell carcinoma in the lung and administered with 2 cans a day of ProSure® and antibiotics. One-and-a-half months later, he underwent chemotherapy with carboplatin and S-1 and radiation. His body weight stood at 47.0 kg on admission and 47.2 kg before discharge, CRP dropped from 15.45 mg/dl to 3.26 mg/dl, and albumin was retained at 2.6 g/dl to 2.7g/dl. The administration of ProSure® brought about improvements in the nutritional status and anti-inflammatory effects in the patients with chemotherapy.
		                        		
		                        		
		                        		
		                        	
9.A Case of Breast Carcinoma with Multiple Bone Metastases Intervened by Palliative Care Preceding Chemotherapy
Hiroaki SHIBAHARA ; Satoshi KOBAYASHI ; Ei SEKOGUCHI ; Yasuyuki FUKAMI ; Akira ITO ; Sakura ONISHI ; Akihiro TOMITA ; Ryo SHIRATSUKI ; Akira KANAMORI ; Kei MIYAMURA ; Yasuhiro KURUMIYA ; Daisaku NISHIMURA
Journal of the Japanese Association of Rural Medicine 2013;62(1):26-30
		                        		
		                        			
		                        			  This case is a 56-year-old woman. With multiple bone metastases, she was referred to the Department of Palliative Care on the same day as core needle biopsy had just been performed in the Department of Surgery. Aggressively increased oxycodone was administered to relieve her significantly severe pains by bone metastases. After relief of the pains, cancer chemotherapy of EC and weekly PTX regimens were performed parallel to palliative care. In this case, chemotherapy could be performed after the pains had been sufficiently relieved with closer cooperation between the palliative care doctor and the attending surgeon. It is important for patient-focused medical care to be delivered by both the attending doctor administering cancer treatment and the palliative care doctor working for relief of the symptoms, while they are striving to foster their tie-up.
		                        		
		                        		
		                        		
		                        	
10.Pregabalin provides remarkable relief of refractory pruritus: a case report
Hiroaki Shibahara ; Akira Ando ; Daisaku Nishimura
Palliative Care Research 2013;8(1):507-510
		                        		
		                        			
		                        			Introduction: It is difficult in the treatment for the patients with refractory pruritus by conventional oral or external medication. Case report: A 72-year-old woman with pancreatic metastasis of primary lung cancer, who was treated by control-release oxycodone for cancer pain and endoscopic biliary drainage for obstructive jaundice. Although external medication and oral anti-allergic agents (mirtazapine and herbal medicine) were administered for pruritus, there was no improvement. The patient was diagnosed with refractory pruritus and pregabalin was administered. After the beginning of low dose, increase of dosage provided improvement at the third day of the administration. Finally, numerical rating scale improved from 8/10 in previous treatment to 0-1/10 in following treatment, and the symptom was relieved. Discussion: A few previous research of effectiveness on pregabalin for pruritus have been reported from abroad. The improvement for refractory pruritus was provided by pregabalin. Conclusion: We conclude that pregabalin is a one of the options for effective treatment for refractory pruritus.
		                        		
		                        		
		                        		
		                        	
            

Result Analysis
Print
Save
E-mail